TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1661490

Group type: EXPERIMENTAL
Intervention: Transcranial electric stimulation (TES) combined with pharmacotherapy (group I)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Transcranial electric stimulation (TES) alone (group II)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Transcranial electric stimulation (TES)
Number of subjects: 189
Study: 6762889

Group type: EXPERIMENTAL
Intervention: Pirenzepine (50 mg three times a day for 4 weeks)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 131
Study: 4063643

Group type: EXPERIMENTAL
Intervention: X ray exposure of 1.0 Gy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: X ray exposure of 0.5 to 1.0 Gy
Number of subjects: 0
Study: 29357488

Group type: EXPERIMENTAL
Intervention: High-intensity roller massage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate-intensity roller massage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham roller massage
Number of subjects: 0
Study: 26867141

Group type: EXPERIMENTAL
Intervention: Endurance exercise training program for 12 weeks
Number of subjects: 15
Study: 25192282

Group type: EXPERIMENTAL
Intervention: Low-dose helical CT scan for lung cancer screening (NLST)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Regular cancer screening (PLCO)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Usual medical care (PLCO)
Number of subjects: 294
Study: 22539590

Group type: EXPERIMENTAL
Intervention: Taspoglutide 10 mg
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Taspoglutide 20 mg
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study: 23437549

Group type: EXPERIMENTAL
Intervention: Vimang for six months
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo for six months
Number of subjects: 68
Study: 18214519

Group type: EXPERIMENTAL
Intervention: Coupled eccentric-concentric contraction training for 36 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Concentric-alone muscle contraction (SQJ)
Number of subjects: 0
Study: 16733277

Group type: EXPERIMENTAL
Intervention: Treatment for giardiasis
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 12
Study: 15004985

Group type: EXPERIMENTAL
Intervention: Evidence-based strategies to change clinical behaviour
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systematic reviews
Number of subjects: 0
Study: 11020032

Group type: EXPERIMENTAL
Intervention: Knowledge of drugs taken prior to admission
Number of subjects: 183

Group type: COMPARATOR
Intervention: Knowledge of drugs received during hospitalization
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Older patients
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Patients with lower education
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Importance rating of drug characteristics
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Sources of drug information
Number of subjects: 183
Study: 9032890

Group type: EXPERIMENTAL
Intervention: Lipoprotein OspA vaccine
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Unlipidated OspA vaccine
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Lipidated OspA vaccine
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 300
Study: 1891755

Group type: EXPERIMENTAL
Intervention: TXA2 synthetase inhibitor (Cataclot) administered to 13 patients by continuous drip infusion at a dose of 1 microgram/kg/min for 8 to 14 days (group A)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (11 patients, group B)
Number of subjects: 24
Study: 6385722

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 30366759

Group type: EXPERIMENTAL
Intervention: Home-based tele-rehabilitation program (n=141)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Conventional care (control group, n=142)
Number of subjects: 283
Study: 28685892

Group type: EXPERIMENTAL
Intervention: Peer-led self-management intervention (INT, n = 232)
Number of subjects: 463

Group type: COMPARATOR
Intervention: Usual care (UC, n = 231)
Number of subjects: 463
Study: 27141951

Group type: EXPERIMENTAL
Intervention: Pro-breastfeeding intervention (six counseling sessions at 7, 15, 30, 60, and 120 days postpartum)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 323
Study: 25100438

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 59

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 59
Study: 22303911

Group type: EXPERIMENTAL
Intervention: Aliskiren/amlodipine 300/10 mg
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Aliskiren/amlodipine 150/10 mg
Number of subjects: 847

Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 847
Study: 19914303

Group type: EXPERIMENTAL
Intervention: Cefaclor (1000 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 17516958

Group type: EXPERIMENTAL
Intervention: Ferrous sulphate tablet (150 g tablet, containing 50 mg of elemental iron) daily throughout pregnancy
Number of subjects: 727

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 727
Study: 16271570

Group type: EXPERIMENTAL
Intervention: Forced-use therapy (FUT) combined with conventional rehabilitation program
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional rehabilitation program only (Control)
Number of subjects: 31
Study: 12140804

Group type: EXPERIMENTAL
Intervention: BiDil (H+ISDN)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study: 9659093

Group type: EXPERIMENTAL
Intervention: 2 ml 75% sucrose solution
Number of subjects: 107

Group type: COMPARATOR
Intervention: Sterile water (control)
Number of subjects: 107
Study: 8127992

Group type: EXPERIMENTAL
Intervention: 41-item La Monica-Oberst Patient Satisfaction Scale (LOPSS)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: 28-item revised La Monica-Oberst Patient Satisfaction Scale (LOPSS)
Number of subjects: 307
Study: 2556172

Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg once daily
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Lisinopril 80 mg once daily
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Lisinopril 1.25 mg once daily
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Lisinopril 5 mg once daily
Number of subjects: 216
Study: 782375

Group type: EXPERIMENTAL
Intervention: Continuous inflating pressure (CIP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Overall survival rate with CIP
Number of subjects: 24

Group type: COMPARATOR
Intervention: Overall survival rate without CIP
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Overall survival rate for infants born in the hospital
Number of subjects: 24

Group type: COMPARATOR
Intervention: Overall survival rate for referred infants
Number of subjects: 24
Study: 31423822

Group type: EXPERIMENTAL
Intervention: Usual care and electrical stimulation to wrist flexors and extensors for 30 minutes, twice a day, five days a week for three months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 40
Study: 27246754

Group type: EXPERIMENTAL
Intervention: Self-ligating brackets
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional brackets
Number of subjects: 25
Study: 25329451

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 97

Group type: COMPARATOR
Intervention: Lean control group
Number of subjects: 97
Study: 21157392

Group type: EXPERIMENTAL
Intervention: Clay courts (CL)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Resin courts (R)
Number of subjects: 6
Study: 19843803

Group type: EXPERIMENTAL
Intervention: Gabapentin 1.2 g and bolus plus infusion of saline
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ketamine 0.3 mg/kg IV bolus and 0.05 mg/kg/h infusion until the end of surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group received oral placebo capsules and bolus plus infusion of saline
Number of subjects: 60
Study: 18269691

Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated; DrotAA) at standard therapy (24 mug/kg per hour for 96 hours)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated; DrotAA) at alternative therapy (higher dose with variable infusion duration or variable infusion duration only)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard therapy (DrotAA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative therapy (DrotAA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DrotAA therapy
Number of subjects: 0
Study: 15238033

Group type: EXPERIMENTAL
Intervention: Melody cues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Title cues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FOK ratings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Knowledge of real titles
Number of subjects: 0
Study: 11679387

Group type: EXPERIMENTAL
Intervention: Structured personal care intervention
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Metformin usage in intervention group
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Follow up consultations arranged by intervention doctors
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Referrals to diabetes clinics by intervention doctors
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Goal setting by intervention doctors
Number of subjects: 874

Group type: COMPARATOR
Intervention: Overall mortality and predefined non-fatal outcomes
Number of subjects: 874
Study: 9205997

Group type: EXPERIMENTAL
Intervention: Ferruginous body concentrations analysis
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Analysis of uncoated asbestos fibers
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Microscopy analysis
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 55
Study: 8262653

Group type: EXPERIMENTAL
Intervention: HibCP-TT vaccination in group A (6 and 7 months)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: HibCP-TT vaccination in group B (5 and 6 months)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: HibCP-TT vaccination in group C (4 and 5 months)
Number of subjects: 144
Study: 3553986

Group type: EXPERIMENTAL
Intervention: Plasma exchange therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study: 30069942

Group type: EXPERIMENTAL
Intervention: Intradialytic Electrical Muscle Stimulation (EMS)
Number of subjects: 29
Study: 27517958

Group type: EXPERIMENTAL
Intervention: Protein breakfast (PRO; 350 kcal; 39 g CHO, 30 g PRO, 8 g fat)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Protein breakfast (PRO)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Breakfast skipping (SKP; no breakfast)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Carbohydrate breakfast (CHO; 351 kcal; 59 g CHO, 10 g PRO, 8 g fat)
Number of subjects: 24
Study: 24717366

Group type: EXPERIMENTAL
Intervention: Iron supplementation from ages 6 to 12 months
Number of subjects: 1123

Group type: COMPARATOR
Intervention: No added iron (formula with iron/powdered cow milk, vitamins without iron)
Number of subjects: 1123
Study: 21927920

Group type: EXPERIMENTAL
Intervention: Denosumab 14 mg
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Denosumab 100 mg
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Denosumab (all doses)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study: 21930490

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Side branch occlusion (EES vs PES)
Number of subjects: 1002
Study: 18160925

Group type: EXPERIMENTAL
Intervention: Intramuscular acupuncture
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Periosteal acupuncture
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 144
Study: 16317360

Group type: EXPERIMENTAL
Intervention: Femostop
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: C-clamp
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Manual compression
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Not receiving eptifibatide (Integrilin)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: No VC prior to femoral sheath removal
Number of subjects: 306
Study: 12534029

Group type: EXPERIMENTAL
Intervention: 24 mg of betamethasone (12 mg every 24 hours)
Number of subjects: 118

Group type: COMPARATOR
Intervention: No antenatal corticosteroids (control group)
Number of subjects: 118
Study: 7900523

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (maximum 800 micrograms)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Intravenous infusion of oxytocin
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 156
Study: 2666476

Group type: EXPERIMENTAL
Intervention: Challenge sucrose drink (2 gm/kg body weight)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo drink sweetened with aspartame
Number of subjects: 12
Study: 23950

Group type: EXPERIMENTAL
Intervention: 25-hydroxycholecalciferol (25-HCC) 150 microgram/day for 20 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vitamin D3 150 microgram/day for 20 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: 25-hydroxycholecalciferol (25-HCC) 75 microgram/day for 20 days (Control Group)
Number of subjects: 20
Study: 30935673

Group type: EXPERIMENTAL
Intervention: BOOST intervention (physiotherapist-delivered physical and psychological intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BOOST intervention
Number of subjects: 0
Study: 28836381

Group type: EXPERIMENTAL
Intervention: Tongue cleaning with mouthwash
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tongue cleaning with mouth moisturising gel
Number of subjects: 12

Group type: COMPARATOR
Intervention: Tongue cleaning with water
Number of subjects: 12

Group type: COMPARATOR
Intervention: No tongue cleaning (negative control)
Number of subjects: 12
Study: 26864365

Group type: EXPERIMENTAL
Intervention: Daily breakfast (≥700 kcal before 1100)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Extended fasting (0 kcal until 1200)
Number of subjects: 23
Study: 22325573

Group type: EXPERIMENTAL
Intervention: MRI-based analysis of hemisphere growth
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: MRI-based analysis of ventricle volume
Number of subjects: 12
Study: 21765272

Group type: EXPERIMENTAL
Intervention: Multimodal physical therapy program plus deep-water running
Number of subjects: 46

Group type: COMPARATOR
Intervention: Multimodal physical therapy program alone
Number of subjects: 46
Study: 18842948

Group type: EXPERIMENTAL
Intervention: Cooling (CT decreased by 0.5 degrees C)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Isothermic (CT remained unchanged)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Thermoneutral (control)
Number of subjects: 14
Study: 17095378

Group type: EXPERIMENTAL
Intervention: Modified open technique preserving the superficial skin nerves
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard open carpal tunnel decompression without preservation of superficial nerve branches
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 42
Study: 15292547

Group type: EXPERIMENTAL
Intervention: Lidocaine-prilocaine cream
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 11742706

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus vinorelbine (G+V) 1200 mg/m(2) plus 30 mg/m(2) on days 1 and 8 every 3 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Vinorelbine (V) 30 mg/m(2) on days 1 and 8 every 3 weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus vinorelbine (G+V)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Vinorelbine (V)
Number of subjects: 120
Study: 9508188

Group type: EXPERIMENTAL
Intervention: Mitomycin plus Ftorafur (MMC-FT)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Mitomycin alone (MMC)
Number of subjects: 85
Study: 7995064

Group type: EXPERIMENTAL
Intervention: Healon GV
Number of subjects: 35

Group type: COMPARATOR
Intervention: Healon
Number of subjects: 35
Study: 2567755

Group type: EXPERIMENTAL
Intervention: sulbactam/ampicillin
Number of subjects: 200

Group type: COMPARATOR
Intervention: cephazolin
Number of subjects: 200
Study: 31843704

Group type: EXPERIMENTAL
Intervention: Incremental methacholine challenge
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Bolus methacholine challenge
Number of subjects: 19
Study: 29677302

Group type: EXPERIMENTAL
Intervention: Uterosacral ligament suspension (ULS)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Sacrospinous ligament fixation (SSLF)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Perioperative behavioral therapy and pelvic floor muscle training (BPMT)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: BPMT
Number of subjects: 285
Study: 28173827

Group type: EXPERIMENTAL
Intervention: iSOLVE intervention
Number of subjects: 560
Study: 25971686

Group type: EXPERIMENTAL
Intervention: Human milk supplemented with FM 85®
Number of subjects: 38

Group type: COMPARATOR
Intervention: Human milk only (Control)
Number of subjects: 38
Study: 23948623

Group type: EXPERIMENTAL
Intervention: Nurse-case-management program
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 36
Study: 21531114

Group type: EXPERIMENTAL
Intervention: Tissue adhesives (2-octyl)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Tissue adhesives (n-butyl-2)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Staples
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Subcuticular suturing
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 75
Study: 19543680

Group type: EXPERIMENTAL
Intervention: Cognitive training program
Number of subjects: 316

Group type: COMPARATOR
Intervention: Control group (no additional intervention)
Number of subjects: 316
Study: 17043070

Group type: EXPERIMENTAL
Intervention: High power output (45 W), short application time (20 s)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Low power output (30 W), long application time (120 s)
Number of subjects: 90
Study: 12774864

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 10647316

Group type: EXPERIMENTAL
Intervention: Spinal manipulation plus soft tissue therapy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Soft tissue therapy plus low-power laser therapy
Number of subjects: 75
Study: 9313125

Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control (no fibrin sealant)
Number of subjects: 95
Study: 8148680

Group type: EXPERIMENTAL
Intervention: Mini flow meter
Number of subjects: 12

Group type: COMPARATOR
Intervention: Spirometer
Number of subjects: 12
Study: 3225688

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31858186

Group type: EXPERIMENTAL
Intervention: Praliciguat 40 mg once daily for days 1-14
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 29289729

Group type: COMPARATOR
Intervention: ART/high-viscosity glass-ionomer cement (HVGIC) for single-surface restorations
Number of subjects: 0

Group type: COMPARATOR
Intervention: ART/high-viscosity glass-ionomer cement (HVGIC) for multiple-surface restorations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amalgam for restorations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ART/high-viscosity glass-ionomer cement (HVGIC)
Number of subjects: 0
Study: 27192696

Group type: EXPERIMENTAL
Intervention: D3
Number of subjects: 38

Group type: COMPARATOR
Intervention: D2
Number of subjects: 38
Study: 25668198

Group type: EXPERIMENTAL
Intervention: GH treatment (1 mg/m²/day) for 4 years
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: GH treatment (1 mg/m²/day) for 9 years
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: GH treatment (1 mg/m²/day) during adolescence
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Higher Tanner stages
Number of subjects: 141
Study: 23000324

Group type: EXPERIMENTAL
Intervention: LUCAS (mechanical chest-compression device)
Number of subjects: 25
Study: 20513828

Group type: EXPERIMENTAL
Intervention: Clinic-based BUP
Number of subjects: 93

Group type: COMPARATOR
Intervention: Referred treatment
Number of subjects: 93
Study: 18211533

Group type: EXPERIMENTAL
Intervention: TPM with a log-transformed EQ-5D index
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LCM
Number of subjects: 0

Group type: COMPARATOR
Intervention: CLAD
Number of subjects: 0

Group type: COMPARATOR
Intervention: OLS and standard TPM
Number of subjects: 0
Study: 16884345

Group type: EXPERIMENTAL
Intervention: Single or repeated doses of kudzu extract
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated doses of kudzu extract
Number of subjects: 0
Study: 12579591

Group type: EXPERIMENTAL
Intervention: Isometric muscle strength measurement in patients with knee OA
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Test-retest reliability of isometric muscle strength measurement
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Random measurement error analysis
Number of subjects: 113

Group type: COMPARATOR
Intervention: Comparison with normative data
Number of subjects: 113
Study: 11503796

Group type: EXPERIMENTAL
Intervention: Levonorgestrel (750 mug per dose)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Ethinyloestradiol (100 mug) + Levonorgestrel (500 mug) combination
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 2000